Testing effectiveness (Phase 2)WithdrawnNCT04535102What this trial is testingPOLA+BR for Relapsed or Refractory DLBCLWho this might be right forDiffuse Large B Cell Lymphoma University of Colorado, Denver
Testing effectiveness (Phase 2)Study completedNCT04605666What this trial is testingCD19-CAR-T2 Cells for CD19 Positive B Cell MalignanciesWho this might be right forB Cell LeukemiaB Cell Lymphoma Nanfang Hospital, Southern Medical University 77
Early research (Phase 1)UnknownNCT04008251What this trial is testingHumanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaB Cell Lymphoma Wuhan Sian Medical Technology Co., Ltd 10
Testing effectiveness (Phase 2)Study completedNCT00006251What this trial is testingFludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerWho this might be right forAcute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more Fred Hutchinson Cancer Center 21
Early research (Phase 1)Not Yet RecruitingNCT07616089What this trial is testingPhase I Study of FXS0683 in the Treatment of Blood TumorsWho this might be right forB-Cell LymphomaAcute Myeloid LeukemiaMyelodysplastic Syndromes+1 more Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 228
Testing effectiveness (Phase 2)Ended earlyNCT04161118What this trial is testingTisaGenlecleucel in Elderly Patients With First-Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin LymphomaWho this might be right forNon Hodgkin Lymphoma University of Cologne 3
Early research (Phase 1)Ended earlyNCT03320642What this trial is testingGRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host DiseaseWho this might be right forHematologic Malignancies Incyte Corporation 84
Testing effectiveness (Phase 2)Study completedNCT01209286What this trial is testingStudy of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)Who this might be right forB-ALL Amgen Research (Munich) GmbH 36
Testing effectiveness (Phase 2)Ended earlyNCT06088654What this trial is testingPhase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin LymphomaWho this might be right forNon Hodgkin Lymphoma Innate Pharma 23
Early research (Phase 1)Study completedNCT00058227What this trial is testingAlvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaWho this might be right forB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular Lymphoma+40 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT05192486What this trial is testingGNC-038, a Tetra-specific Antibody, in Participants With R/R Diffuse Large B-cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B-cell Lymphoma Sichuan Baili Pharmaceutical Co., Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT07508605What this trial is testingEfficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell LymphomaWho this might be right forRelapsed/Refractory B-cell Lymphoma Shenzhen University General Hospital 20
Not applicableStudy completedNCT07103486What this trial is testingEvaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma Novartis Pharmaceuticals 264
Testing effectiveness (Phase 2)Study completedNCT02207062What this trial is testingIbrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin LymphomaWho this might be right forRecurrent Transformed B-Cell Non-Hodgkin LymphomaRefractory Transformed B-Cell Non-Hodgkin Lymphoma University of Washington 20
Testing effectiveness (Phase 2)Study completedNCT00445341What this trial is testingFlavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell LymphomaWho this might be right forLymphoma National Cancer Institute (NCI) 28
Early research (Phase 1)Study completedNCT00003166What this trial is testingBryostatin and Vincristine in B-Cell MalignanciesWho this might be right forRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Diffuse Mixed Cell Lymphoma+7 more National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)WithdrawnNCT03880279What this trial is testingAutologous TAC T Cells Targeting CD19 in R/R Large B-Cell LymphomaWho this might be right forLymphoma, B-Cell Triumvira Immunologics, Inc.
Not applicableActive Not RecruitingNCT07709624What this trial is testingEvaluating the Treatment Outcomes of Tafasitamab in Patients With Relapsed/ Refractory Diffuse Large B-cell Lymphoma: a Real-world Evidence StudyWho this might be right forDLBCL TTY Biopharm 50
Testing effectiveness (Phase 2)UnknownNCT05816746What this trial is testingDecitabine and Anti-PD-1 in R/R DLBCLWho this might be right forDiffuse Large B Cell LymphomaRelapse/RecurrenceExtranodal Extension+1 more Chinese PLA General Hospital 20
Very early researchLooking for participantsNCT07429461What this trial is testingClinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic LeukemiaWho this might be right forB-Cell Acute Lymphoblastic Leukemia Zhejiang University 16